Significant associations between the mRNA expression of ADAM9 in RCC and clinico-pathological parameters (tumour stage, grading, nodal status, metastasis, histologic type and residual tumour status) could not be demonstrated (all p > 0.05). Here, ADAM9 is linked to neoplasm.